02677 卓正醫療
DISTINCT HEALTH
DISTINCT HEALTH
| Register Close | 2026/02/03 IPO Closing in 5 Days |
| Listing Date | 2026/02/06 |
|
|
|
|
|
|
|
|
|
|
IPO Detail
COMPANY PROFILE
Distinct Healthcare Holdings has been strategically focusing on serving the mid- to high-end healthcare service market, targeting mass affluent and wealthy population that generally has stronger purchasing power and a preference for more personalized care. The Group is the third largest private mid- to high-end comprehensive healthcare service provider in China in terms of revenue in 2024 with a market share of 2%, according to the report.
--
Leveraging the Group’s range of specialties including pediatrics, dentistry, eye care, dermatology, ENT & general surgery, women’s health, and internal medicine as well as close collaborations among specialists, it is able to serve the diverse medical needs of patients and their whole families, which allows it to continuously increase patient satisfaction and generate cross-referral opportunities.
--
As of January 20, 2026, the Group owned and operated 19 healthcare service institutions, including 17 clinics and two hospitals, strategically covering 11 cities across China, and four general practice clinics in Singapore and one general practice clinic in Malaysia.
--
All of the Group’s healthcare service institutions are private for-profit healthcare service institutions operated under our brand name “Distinct HealthCare”. Its revenue derived primarily from the provision of healthcare services, mainly including in-person healthcare services and tele-healthcare services.
BASIC INFORMATION
| Market | Hong Kong (Main Board) |
| Business Nature | Health Care |
| Major Business Area | China |
| Board Lot | 50 |
GLOBAL OFFERING
| No. of Offer Shares | 4.75M shares |
| No. of International Offer Shares | 4.28M shares |
| No. of HK Offer Shares | 0.48M shares |
| Offer Price | $57.70 - $66.60 |
| Stock Code | 2677 |
| Sponsor(s) | Haitong International Capital Limited, SPDB International Capital Limited |
| Underwriter(s) | Haitong International Securities Company Limited, SPDB International Capital Limited, CMB International Capital Limited, China Galaxy International Securities (Hong Kong) Co., Limited, CCB International Capital Limited, ICBC International Securities Limited, China Renaissance Securities (Hong Kong) Limited, Zhongtai International Securities Limited, Futu Securities International (Hong Kong) Limited, Funde Securities Limited, Tiger Brokers (HK) Global Limited |
TIME TABLE
| Application Period | Jan 29 (Thu) - noon, Feb 03 (Tue) |
| Price Determination Date | Feb 04 (Wed) |
| Result Announcement Date | On or before Feb 05 (Thu) |
| Result Announcement Date | On or before Feb 05 (Thu) |
| Result Announcement Date | On or before Feb 06 (Fri) |
| Dealings in Shares commence on | Feb 06, 2026. (Fri) |
Reallocation of Shares Offered
Sales Statistics (HKD)
| Offer Price | $57.70 - $66.60 |
| Capitalization | 3.71B - 4.29B |
| NAV / share ($) | $13.04 - $13.73 (Unaudited pro forma adj NAV / share) |
Use Of Proceeds
| Assuming the offer price being at HKD 62.15, the net proceeds raised would be HKD 219.10M, of which |
| 35% : Improvements to own information technology systems by in-house information and data technology department |
| 30% : Upgrading existing healthcare service institutions and establishing new healthcare service institutions |
| 25% : Acquiring healthcare service institutions in Tier-One Cities that have demonstrated a good track record of performance |
| 10% : Working capital |
Related Document
| Prospectus |  Chinese Version | English Version |
| Remark： | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --Offer Price︰--
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).